Gil-Salcedo A, Massart R, Cleret de Langavant L, Bachoud-Levi AC. Modifiable factors associated with Huntington's disease progression in presymptomatic participants. Ann Clin Transl Neurol. 2024 Jul;11(7):1930-1941.
Dallery R, Fraisse N, Cleret de Langavant L, Youssov K, Morgado G, Massart R, Schubert R, Reilmann R, Jacquemot C, Bapst B, Busse M, Craufurd D, Rosser A, Lunven M, Bachoud-Lévi AC. The Joint Memory Effect: Challenging the Selfish Stigma in Huntington’s Disease? Brain Commun. 2024 Dec 9;7(1):fcae440. doi: 10.1093/braincomms/fcae440.
Chea M, Cleret de Langavant L, Delorme C, Corvol JC, Delemazure J, Morawiec E, Faure M, Pichon B, Bayen E, Stefanescu F. Prevalence and typology of hallucinatory phenomena in adults with COVID-19: Early experiences at the post-acute phase in step down unit. Ann Phys Rehabil Med. 2025 Apr 18;68(5):101970. doi: 10.1016/j.rehab.2025.101970.
Gharbi-Meliani A, Husson F, Vandendriessche H, Bayen E, Yaffe K, Bachoud-Lévi AC, Cleret de Langavant L. Identification of High Likelihood of Dementia in Population-Based Surveys using Unsupervised Clustering: a Longitudinal Analysis. Alzheimer Research & Therapy, 2023 Nov 29;15(1):209. doi: 10.1186/s13195-023-01357-9.
Cleret de Langavant L, Roze E, Petit A, Tressières B, Gharbi-Meliani A, Chaumont H, Michel PP, Bachoud-Lévi AC, Remy Ph, Edragas R, Lannuzel A. Annonaceae consumption worsens disease severity and cognitive deficits in degenerative Parkinsonism. Mov Disord. 2022 Oct 10. doi: 10.1002/mds.292.
Bayen E, Cleret de Langavant L, Youssov K, Bachoud-Lévi AC. Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors. Ann. Phys. Rehab. Med. 2022 Aug 30:101703. doi: 10.1016/j.rehab.2022.101703. PMID: 36055643
Lemercier P, Cleret de Langavant L, Hamet Bagnou J, Youssov K, Lemoine L, Audureau E, Massart R, Bachoud-Lévi A-C. Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease. J. Pers. Med. 2022, 12(2), 174; https://doi.org/10.3390/jpm12020174
Riad R, Lunven M, Titeux H, Cao XN, Hamet Bagnou J, Lemoine L, Montillot J, Sliwinski A, Youssov K, Cleret de Langavant L, Dupoux E, Bachoud-Lévi AC. Predicting clinical scores in Huntington's disease: a lightweight speech test. J Neurol. 2022 Sep;269(9):5008-5021. doi: 10.1007/s00415-022-11148-1.
Segaux L, Oubaya N, Leissing-Desprez C, Cleret De Langavant L, Broussier A, Naga H, Fromentin I, David JP, Bastuji-Garin S. More than a third of middle-aged adults (50-65) have understated executive dysfunction. Aging Ment Health. 2022 Mar 4:1-6. doi: 10.1080/13607863.2022.2046696.
Lemoine L, Lunven M, Bapst B, Cleret de Langavant L, de Gardelle V, Bachoud-Lévi AC. The specific role of the striatum in interval timing: The Huntington's disease model. Neuroimage Clin. 2021;32:102865.
Fénelon G, Parant J, Cleret de Langavant L. Victor Parant (1848-1924) and the first report of psychosis in the course of Parkinson’s disease with dementia. Rev. Neurol (Paris). 2021 Jul 8; S0035-3787(21)00589-0. Doi: 10.1016/j.neurol.2021.03.004.
Grosset L, Hosseini H, Bapst B, Hodel J, Cleret de Langavant L, Faugeras F, Bachoud-Lévi AC, Seddik L. Mild encephalopathy with reversible splenial lesion: Description of nine cases and review of the literature. Seizure, 2021 May; 88:83-86. Doi: 10.1016/j.seizure.2021.03.032.
Cleret de Langavant L, Petit A, Nguyen QTR, Gendre T, Abdelhedi J, Djellaoui A et al. Clinical description of the broad range of neurological presentations of COVID-19: a retrospective case series. Rev Neurol, 2021 Mar;177(3):275-282. doi: 10.1016/j.neurol.2021.01.004. Epub 2021 Feb 11. PMID: 33610347
Leissing-Desprez C, Thomas E, Segaux L, Broussier A, Oubaya N, Marie-Nelly N et al. Understated Cognitive Impairment Assessed with the Clock-Drawing Test in Community-Dwelling Individuals Aged +50 Years. J Am Med Dir Assoc, 2020; 21, 1658-1664.
Bayen E, Yaffe K, Cleret de Langavant L, Chen Y, Possin KL. The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer's disease among 2015 Californian beneficiaries. Ann Phys Rehabil Med. 2020 Aug 24:S1877-0657(20)30158-5. doi: 10.1016/j.rehab.2020.07.011.
Cleret de Langavant L, Bayen E, Bachoud‐Lévi A-C, Yaffe K. Approximating dementia prevalence in population‐based surveys of aging worldwide: An unsupervised machine learning approach. Alzheimer's Dement. 2020; 6:e12074. https://doi.org/10.1002/trc2.12074
Djellaoui, A, Seddik, L, Cleret De Langavant, L, Cattan, S, Bachoud-Lévi, AC, Hosseini, H. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection. J Neurol Neurosurg Psychiatry, 2020, Jul 27:jnnp-2020-323923. doi: 10.1136/jnnp-2020-323923
Bachoud-Lévi, AC , et al. Human Fetal Cell Therapy in Huntington''s Disease: A Randomized, Multicenter, Phase II Trial. Mov Disord, 2020, 35, 1323-1335
Nguyen R, Gravier A, Lesoil C, Bedet A, Petit-Hoang C, Mahevas M, Mekontso-Dessap A, Hodel J, Bachoud-Lévi AC, Cleret de Langavant L. Acute Hippocampal Encephalopathy in heavy cannabis users: about two cases. Am J Med, 133, e360-e364.
Oosterloo, M, Bijlsma, EK, van Kuijk, SM, Minkels, F, de Die-Smulders, CE and the Registry investigators group. Clinical and genetic characteristics of late-onset Huntington's disease., Parkinsonism Relat Disord, 2018 Nov 29. pii: S1353-8020(18)30490-5.
Giavazzi M, Daland R, Palminteri S, Peperkamp S, Brugières P, Jacquemot C, Schramm C, Cleret de Langavant L, Bachoud-Lévi A-C. The role of the striatum in linguistic selection: Evidence from Huntington’s disease and computational modeling. Cortex. 2018 Sep 15;109:189-204.
Bayen E, Possin KL, Chen Y, Cleret de Langavant L, Yaffe K. Prevalence of Aging, Dementia and Multimorbidity in Older Adults with Down Syndrome. JAMA Neurol. 2018 Jul 22. doi: 10.1001/jamaneurol.2018.2210.
Cleret de Langavant L, Bayen E, Yaffe K. Unsupervised machine learning to identify high likelihood of dementia in population-based surveys. J Med Internet Res. 2018 Jul 9;20(7):e10493.
Trinkler I, Devignevielle S, Achaibou A, Ligneul RV, Brugières P, Cleret de Langavant L, De Gelder B, Scahill R, Schwartz S, Bachoud-Lévi AC. Embodied emotion impairment in Huntington's Disease. Cortex. 2017;92:44-56.
Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network. Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944.
Salem L, Saleh N, Désaméricq G, Youssov K, Dolbeau G, Cleret de Langavant L, Bourhis ML, Azulay JP, Krystkowiak P, Verny C, Morin F, Moutereau S, French Huntington Study Group, Bachoud-Lévi AC, Maison P. Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PLoS ONE. 2016 Sep 14;11(9):e0162890. doi: 10.1371/journal.pone.0162890.eCollection 2016.
Soulas, T, Cleret de Langavant, L, Monod, V, Fénelon, G. The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over., Int J Geriatr Psychiatry, 2016, 31, 1322-1328.
Carteaux G, Maquart M, Bedet A, Contou D, Brugières P, Fourati et al. Zika Virus Associated with Meningoencephalitis., N. Engl. J. Med., 2016, 374, 1595-6.
Van Der Gucht A, Cleret de Langavant L, Bélissant O, Rabu C, Cottereau AS, Evangelista et al. , Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease., Nucl Med Mol Imaging, 2016, 50, 258-60.
Cleret de Langavant, L, Jacquemot, C, Cruveiller, V, Dupoux, E, Bachoud-Lévi, AC. Pointing to others: How the target gender influences pointing performance., Cogn Neuropsychol, 2016, 33, 343-51.
de Diego-Balaguer R, Schramm C, Rebeix I, Dupoux E, Durr A, Brice et al. , COMT Val158Met Polymorphism Modulates Huntington's Disease Progression., PLoS ONE, 2016, 11, e0161106.
Schramm C, Katsahian S, Youssov K, Démonet JF, Krystkowiak P, Supiot et al., How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease., PLoS ONE, 2015, 10, e0145842.
Cleret de Langavant L, Sudraud S, Verny C, Krystkowiak P, Simonin C, Damier P, Demonet JF, Supiot F, Rialland A, Schmitz D, Maison P, Youssov K, Bachoud-Lévi AC. Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting. PLoS One (2015) 10(5):e0128209.
Contou D, Dacheux L, Bendib I, Jolivet S, Rodriguez C, Tomberli F, Cleret de Langavant L, Lavenir R, Lepelletier A, Larrous F, Troupin C, Bourhy H, Brun-Buisson C. Severe ketoalkalosis as initial presentation of human rabies imported in France. J. Clin. Microbiol. Epub online 8 april 2015.
Désaméricq G, Dolbeau G, Verny C, Charles P, Durr A, Youssov K, Simonin C, Azulay JP, Tranchant C, Goizet C, Damier P, Broussolle E, Demonet JF, Morgado G, Cleret de Langavant L, Macquin-Mavier I, Bachoud-Lévi AC, Maison P. Effectiveness of anti-psychotics and related drugs in the Huntington French-Speaking Group cohort. PLoS One (2014) 9, e85430.
Youssov K, Dolbeau G, Maison P, Boissé MF, Cleret de Langavant L, Roos RA, Bachoud-Lévi AC. The unified Huntington's disease rating scale for advanced patients: Validation and follow-up study. Mov Disord (2013), 28, 1995-2001.
Trinkler I, Cleret de Langavant L, Bachoud-Lévi AC. Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex (2013), 49, 549-58.
Cleret de Langavant L, Jacquemot C, Bachoud-Lévi AC, Dupoux E. The second person in "I"-"you"-"it" triadic interactions. Behavioral and Brain Sciences (2013), 36, 416-7.
Cleret de Langavant L, Fénelon G, Benisty S, Boissé MF, Jacquemot C, Bachoud-Lévi AC. Awareness of memory deficits in early stage Huntington's disease. PLoS One (2013), 8, e61676.
Cleret de Langavant L, Trinkler I, Remy P, Thirioux B, McIntyre J, Berthoz A, Dupoux E, Bachoud-Lévi AC. Viewing another person's body as a target object: a behavioural and PET study of pointing. Neuropsychologia (2012), 50, 1801-13.
Bayen E, Cleret de Langavant L, Fénelon G. Le syndrome d'Alice au pays des merveilles : une aura migraineuse inhabituelle. Rev Neurol (Paris) (2012), 168, 457-9.
Cleret de Langavant L, Remy P, Trinkler I, McIntyre J, Dupoux E, Berthoz A, Bachoud-Lévi AC. Behavioral and neural correlates of communication via pointing. PLoS One (2011), 6, e17719.
Fénelon G, Soulas T, Cleret de Langavant L, Trinkler I, Bachoud-Lévi AC. Feeling of presence in Parkinson's disease. J Neurol Neurosurg Psychiatry (2011), 82, 1219-24.
Fénelon G, Soulas T, Zenasni F, Cleret de Langavant L. The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord (2010), 25, 763-6.
Cleret de Langavant L, Trinkler I, Cesaro P, Bachoud-Lévi AC. Heterotopagnosia: When I point at parts of your body. Neuropsychologia (2009), 47, 1745-55.